Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study

Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study

Background Real-life studies in psoriasis are lacking. Many monoclonal antibodies targeting tumor-necrosis factor (TNF)-alpha, interleukin 17, and 23 are approved drugs for psoriasis treatment. Objectives To compare the short and long-term efficacy, safety, and drug survival of anti TNF-alpha, anti-...

Full description

Bibliographic Details
Main Authors: Paolo Dapavo, Niccolò Siliquini, Luca Mastorino, Gianluca Avallone, Martina Merli, Andrea Agostini, Caterina Cariti, Riccardo Viola, Elena Stroppiana, Anna Verrone, Michela Ortoncelli, Pietro Quaglino, Simone Ribero
Format: Article
Language:English
Published: Taylor & Francis Group 2022-05-01
Series:Journal of Dermatological Treatment
Subjects:
psoriasis
biological therapy
pasi
drug survival
Online Access:http://dx.doi.org/10.1080/09546634.2021.1961998

Internet

http://dx.doi.org/10.1080/09546634.2021.1961998

Similar Items